Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


SAFC Pharma to invest $30 million in expansion plan

This article was originally published in Scrip

Executive Summary

SAFC Pharma will invest $30 million in an expansion plan designed to increase its commercial production of high potency active pharmaceutical ingredients. The firm, which is a subsidiary ofSigma-Aldrich, will build a new 45,000 sq ft manufacturing facility on 15 acres of land near its existing site in Verona, Wisconsin. The facility will include new laboratories, a 150 litre mini-processing plant and two large-scale cGMP manufacturing suites. SAFC Pharma said that the plant's construction would be completed by the end of 2009.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts